24-11-24
ஆறிய புண்ணைக் கிளறும் தீர்ப்பு !அரசு மருத்துவமனைகள் சந்திக்கும் பிரச்னைகள்கழகங்களின் சுயநல அரசியல் - சாடிய நீதிபதி .....!மகாயுதியும், மகாவிஹாஸ் அகாதியும்நினைத்துப் பார்க்கிறேன்என்ன நினைக்கிறார் எடப்பாடி பழனிசாமி?"வாட்ஸ்அப், ஃபேஸ்புக் பயன்பாடு அதிகரிப்பதால் தமிழ் இலக்கியங்கள் அழிந்து விடாது!" - பேராசிரியர் கு.ஞானசம்பந்தன்ஜன்னல் வழியேஅரசு டாக்டர்களுக்கும் கௌன்சிலிங் தேவை !சொல் நாயகம்மேற்கு மாவட்ட செய்திகள்நாட்டை ஆட்டிப் படைத்து வரும் இலவசங்கள் !பள்ளிப் பாடத் திட்டம் - குறை நீக்கும் புதிய குழுடெல்லி டைரிிமஹாபாரதம் பேசுகிறது - சோடியர் மிஸ்டர் துக்ளக்கார்டூன் சத்யாகார்டூன் ராஜுகார்டூன் அட்டை
Email to editor
Email to Support
Thuglak Online Store
Cho's Collections


Kathadi Ramamurthi's


Tamil Telefilms
6 VCD/DVD Collections


Bharatanatyam
5 - VCD/DVD Collections


Yoga
8 - VCD/DVD Collections


Carnatic Music - Vocal
25 - VCD/DVD Collections


Devotional
21 - VCD/DVD Collections


Carnatic Music - Instrument
10 - VCD/DVD Collections


Mouli's
6 - VCD/DVD Collections


Crazy's
22 - VCD/DVD Collections


S.Ve.Shekher's
15 - VCD/DVD Collections


Kuchupudi
6 VCD/DVD Collections


Y.Gee.Mahendra's
8 - VCD/DVD Collections


Dummies Drama's
6 - VCD/DVD Collections

India to produce raw material for swine flu drug, toll touches 220

Category :India Sub Category :National,Health
2009-09-17 00:00:00
   Views : 1467

New Delhi, Sep 17 - India is working overtime to come out with a swine flu vaccine and will soon produce the raw material used in the anti-flu drug, the government said Thursday as eight more people died of the influenza A (H1N1) virus, taking the toll to 220.

Union Health Minister Ghulam Nabi Azad said 'India is taking prompt and proactive measures to delay and limit the spread of the diseases and also to build capacity to mitigate the impact of the pandemic.'

He said India was among the first few countries to stake claim to produce the vaccine.

'Three companies - Serum Institute, Panaxea Bio-Tech and Bhatat Biotech are working on this and the government has given Rs.100 million each to these institutes,' he told reporters here.

'The vaccine is likely to be available by April next year,' he added.

He said the ministry is also in touch with multinational companies working on producing the swine flu vaccine. 'We are in touch with them and will import the vaccine if they prepare it first,' he added.

Azad said presently there are 53 laboratories - 31 government and 22 private - that are conducting the H1N1 tests, as compared to two when the flu was first reported in India on May 16.

Of these, 34 labs - 22 government and 12 private - are operational.

The government has also increased its medicine stockpile with 10 million Oseltamivir capsules, one of the anti-influenza drugs, to 40 million capsules, and 450,000 bottles of Oseltamivir syrup.

'We have also permitted regulated sale and distribution of Oseltamivir and Zanamivir. Both these drugs will be available in retail markets against proper medical prescription from chemists having a license,' he said.

He said India will soon produce raw material for Oseltamivir, one of the drugs used in treatment of Influenza A (H1N1) virus. This will help bring down the cost of the drug.

'We have decided to allow indigenous production of shikimic acid,' Azad said.

Shikimic acid, a white crystalline compound of nonnitrogenous acid found in various plants naturally, is needed to produce Oseltamivir.




Author :Indo Asian News Service



Bookmark and Share

Related News

  • First Test: India vs. Sri Lanka, lunch, Day 1 scoreboard
  • First Test: India 105/4 against Sri Lanka at lunch
  • Kabuliwala beckons Indians at international trade fair
  • India's Sensex tops 17,000 points, Nifty rules above 5,000
  • First Test: India vs. Sri Lanka, lunch, Day 1 scoreboard
  • First Test: India 105/4 against Sri Lanka at lunch
  • Kabuliwala beckons Indians at international trade fair
  • India's Sensex tops 17,000 points, Nifty rules above 5,000